相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis
Vanja Pekovic-Vaughan et al.
GENES & DEVELOPMENT (2014)
Urokinase-type Plasminogen Activator Receptor ( uPAR) Ligation Induces a Raft-localized Integrin Signaling Switch That Mediates the Hypermotile Phenotype of Fibrotic Fibroblasts
Lisa M. Grove et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Fibrotic extracellular matrix activates a profibrotic positive feedback loop
Matthew W. Parker et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Nrf2 Amplifies Oxidative Stress via Induction of Klf9
Shoshanna N. Zucker et al.
MOLECULAR CELL (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rituximab in severe, treatment-refractory interstitial lung disease
Gregory J. Keir et al.
RESPIROLOGY (2014)
Interstitial Lung Disease in Systemic Sclerosis
Athol U. Wells et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Immunosuppression for Connective Tissue Disease-Related Pulmonary Disease
Toby M. Maher
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes
Rongrong Wei et al.
TRANSLATIONAL RESEARCH (2014)
Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis
David M. Habiel et al.
FRONTIERS IN PHARMACOLOGY (2014)
The epithelium in idiopathic pulmonary fibrosis: breaking the barrier
Ana Camelo et al.
FRONTIERS IN PHARMACOLOGY (2014)
Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis
Chang-Min Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
Telomerase and Telomere Length in Pulmonary Fibrosis
Tianju Liu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis
Willems Stijn et al.
ANNALS OF THORACIC MEDICINE (2013)
Host Responses in Tissue Repair and Fibrosis
Jeremy S. Duffield et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 8 (2013)
Diagnosis and Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease
Rekha Vij et al.
CHEST (2013)
Nonsteroidal therapy of sarcoidosis
Peter Korsten et al.
CURRENT OPINION IN PULMONARY MEDICINE (2013)
Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis
Jonathan A. Kropski et al.
DISEASE MODELS & MECHANISMS (2013)
ROCKing pulmonary fibrosis
Dean Sheppard
JOURNAL OF CLINICAL INVESTIGATION (2013)
Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis)
Swati Bhattacharyya et al.
JOURNAL OF PATHOLOGY (2013)
PAR-1 antagonists: current state of evidence
Saurav Chatterjee et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study
Stylianos T. Panopoulos et al.
LUNG (2013)
The K+ Channel KCa3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis
Katy Morgan Roach et al.
PLOS ONE (2013)
Adult stem cells for chronic lung diseases
Ana L. Mora et al.
RESPIROLOGY (2013)
Latest advances in connective tissue disorders
Vijay Rao et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2013)
Common pathways in idiopathic pulmonary fibrosis and cancer
Carlo Vancheri
EUROPEAN RESPIRATORY REVIEW (2013)
The role of infection in the pathogenesis of idiopathic pulmonary fibrosis
Philip L. Molyneaux et al.
EUROPEAN RESPIRATORY REVIEW (2013)
Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future
Katerina M. Antoniou et al.
EUROPEAN RESPIRATORY REVIEW (2013)
Significance of connective tissue diseases features in pulmonary fibrosis
Vincent Cottin
EUROPEAN RESPIRATORY REVIEW (2013)
Recommendations on treatment for IPF
Juergen Behr et al.
RESPIRATORY RESEARCH (2013)
Role of Sonic Hedgehog in idiopathic pulmonary fibrosis
Alfredo Lozano Bolanos et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
Imre Noth et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Targeting NOX enzymes in pulmonary fibrosis
Louise Hecker et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Familial forms of nonspecific interstitial pneumonia/idiopathic pulmonary fibrosis: clinical course and genetic background
Raphael Borie et al.
CURRENT OPINION IN PULMONARY MEDICINE (2012)
Alveolar epithelial type II cells from embryonic stem cells: knights in shining armour?
H. Fehrenbach
EUROPEAN RESPIRATORY JOURNAL (2012)
Triple therapy in idiopathic pulmonary fibrosis: an alarming press release
A. U. Wells et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Fasudil, a Rho-Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
Chunguo Jiang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Nintedanib (BIBF 1120) for IPF: a tomorrow therapy?
Sabina A. Antoniu
MULTIDISCIPLINARY RESPIRATORY MEDICINE (2012)
Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis
Andreas Guenther et al.
EUROPEAN RESPIRATORY REVIEW (2012)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Integrating mechanisms of pulmonary fibrosis
Thomas A. Wynn
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Early growth response transcription factors: Key mediators of fibrosis and novel targets for anti-fibrotic therapy
Swati Bhattacharyya et al.
MATRIX BIOLOGY (2011)
Blocking TGF beta via Inhibition of the alpha v beta 6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease
Tamiko R. Katsumoto et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2011)
Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
Argyris Tzouvelekis et al.
PULMONARY MEDICINE (2011)
Does Chronic Microaspiration Cause Idiopathic Pulmonary Fibrosis?
Joyce S. Lee et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Imatinib Treatment for Idiopathic Pulmonary Fibrosis Randomized Placebo-controlled Trial Results
Craig E. Daniels et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis
Corrine R. Kliment et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Pulmonary Epithelium Is a Prominent Source of Proteinase-activated Receptor-1-inducible CCL2 in Pulmonary Fibrosis
Paul F. Mercer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept An Exploratory, Placebo-controlled Trial
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?
R. C. Chambers
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis
Melanie Koenigshoff et al.
PLOS ONE (2008)
分享论文
